Replies to post #242897 on Elite Pharmaceuticals Inc (ELTP)

[NASDAQ2020]

SequestOx has three clear pathways to approval.
FDA liked all three reformulated oxy beads.
The Invitro data was brought to FDA meeting in DEC.
The fed Tmax has been corrected, Invivo trials starting before Mar 31.
Elite will end up with the ONLY IR ADF labeled opiod in the world.
Elite will take its share of the $8 billion dollar IR opiod market.

Im accumulating right up till approval, GL

[Chasing]

Which specific fact is nonsensical? None.